Laura B. Prickett

Small molecule AZD4635 inhibitor of A_2AR signaling rescues immune cell function including CD103⁺ dendritic cells enhancing anti-tumor immunity

Alexandra Borodovsky, Christine M. Barbon, Yanjun Wang et al. · Journal for ImmunoTherapy of Cancer · 2020 · 102 citations · Full text

Medicine, Immunology, Pharmacology +17

Systemic nano-delivery of low-dose STING agonist targeted to CD103+ dendritic cells for cancer immunotherapy

Aatman S. Doshi, Susan Cantin, Laura B. Prickett et al. · Journal of Controlled Release · 2022 · 64 citations

Life Sciences, Immunology, Oncology +17

PARP inhibition is a modulator of anti-tumor immune response in BRCA-deficient tumors

Anna D. Staniszewska, Joshua Armenia, Matthew King et al. · OncoImmunology · 2022 · 49 citations · Full text

Life Sciences, Immunology, Oncology +17

Age-induced changes in anti-tumor immunity alter the tumor immune infiltrate and impact response to immuno-oncology treatments

Suzanne I. Sitnikova, Jennifer A. Walker, Laura B. Prickett et al. · Frontiers in Immunology · 2023 · 15 citations · Full text

Medicine, Immunology, Oncology +17

Degradation of IKZF1 prevents epigenetic progression of T cell exhaustion in an antigen-specific assay

Tristan Tay, Gayathri Bommakanti, Elizabeth Jaensch et al. · Cell Reports Medicine · 2024 · 12 citations · Full text

Life Sciences, Immunology, Molecular Biology +17